David Barthel - Feb 8, 2022 Form 4 Insider Report for MARIZYME INC (MRZM)

Role: Chief Executive Officer, Director
Signature: /s/ David Barthel
Stock symbol: MRZM
Transactions as of: Feb 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/9/2022, 04:17 PM
Previous filing: Jan 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRZM	Stock Options (right to buy)	Disposed to Issuer		-400K	-100%		0	Feb 8, 2022	Common Stock	400K	$2.25	Direct	F1
transaction	MRZM	Stock Options (right to buy)	Award		+400K			400K	Feb 8, 2022	Common Stock	400K	$1.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted as of October 31, 2021. The option vested as to 40,000 shares upon the original option's grant date of October 31, 2021 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated as of October 31, 2021, as amended on February 8, 2022. The balance of 360,000 shares vest on a quarterly basis over the three (3) year period following October 31, 2021 in equal installments.

Content

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted as of October 31, 2021. The option vested as to 40,000 shares upon the original option's grant date of October 31, 2021 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated as of October 31, 2021, as amended on February 8, 2022. The balance of 360,000 shares vest on a quarterly basis over the three (3) year period following October 31, 2021 in equal installments.